Speaker:

Hadia Ahmad, MD

IM Resident PGY-3

No Disclosures

Objectives:

•Define treatment resistant hypertension.

•Understand the role of endothelin and aldosterone in the pathophysiology of hypertension.

•Recognize the endothelin pathway as a target for treatment of resistant hypertension.

•Review current research investigating endothelin-receptor antagonists and aldosterone synthase in the treatment of hypertension.